Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: A therapeutic benefit for arthritis
Article first published online: 26 FEB 2010
Copyright © 2011 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 63, Issue 4, pages 1010–1020, April 2011
How to Cite
Kok, S.-H., Hou, K.-L., Hong, C.-Y., Wang, J.-S., Liang, P.-C., Chang, C.-C., Hsiao, M., Yang, H., Lai, E. H.-H. and Lin, S.-K. (2011), Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: A therapeutic benefit for arthritis. Arthritis & Rheumatism, 63: 1010–1020. doi: 10.1002/art.27433
- Issue published online: 26 FEB 2010
- Article first published online: 26 FEB 2010
- Accepted manuscript online: 4 AUG 2010 12:19PM EST
- Manuscript Accepted: 16 FEB 2010
- Manuscript Received: 19 AUG 2009
- National Science Council of Taiwan. Grant Numbers: NSC98-2314-B-002-069-MY3, NSC96-2314-B-002-180-MY3
- 4Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice. Arthritis Rheum 2003; 48: 1750–61., , , , , , et al.
- 5MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M–stimulated CCL2 expression in human osteoblasts through a common transcription factor. Arthritis Rheum 2004; 50: 785–93., , , , , , et al.
- 13Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins. Arthritis Rheum 2006; 54: 2047–60., , , , , , et al.
- 27Up-regulated phosphorylation of signal transducer and activator of transcription 3 and cyclic AMP-responsive element binding protein by peripheral inflammation in primary afferent neurons possibly through oncostatin M receptor. Neuroscience 2005; 133: 797–806., , .
- 30Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis. Arthritis Rheum 2008; 58: 3145–56., , , , , , et al.
- 31Oncostatin M–induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: an implication for the pathogenesis of arthritis. Arthritis Rheum 2009; 60: 1451–62., , , , , , et al.
- 40Food and Drug Administration (US). Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Rockville (MD): Dept. of Health and Human Services (US), Center for Drug Evaluation and Research; 2005. URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM078932.pdf.